Literature DB >> 8494714

Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.

G Castiglione1, M Biagini, A Barchielli, G Grazzini, A Mazzotta, P Salvadori, L Scillone, S Ciatto.   

Abstract

Screening for colorectal cancer by means of unhydrated Hemoccult (HO) is in progress in the Province of Florence since 1982. In 1990 rehydrated HO was introduced in the town of Empoli. Five adjacent municipalities where screening had started in 1987 were selected for comparison. In both areas subjects aged 40-70 were invited by mail to undergo the screening protocol. HO-positive subjects were invited to undergo either pancolonoscopy or a combination of left colonoscopy and double contrast barium enema. HO-negative subjects were invited to repeat screening 2 years later. The positivity rate of HO was significantly higher (P < 0.001) for rehydrated (5%) as compared to unhydrated (3.1%) HO. The positive predictive values for cancer (unhydrated: 5.8%; rehydrated: 8.9%) and for adenomas (unhydrated: 26.7%; rehydrated: 25.5%) did not significantly differ. The detection rates of rehydrated HO were significantly higher as compared to unhydrated HO both for cancer (0.37% vs 0.15%; P < 0.05) and adenomas (1.06% vs 0.72%; P < 0.05%). In the present experience rehydration doesn't produce any decrease in the positive predictive value for cancer or adenomas and the increase in the positivity rate appears quite acceptable when considering the significant increase in the detection rates of cancer and adenomas. We conclude that rehydrated HO should be introduced as the standard test for screening in order to increase sensitivity for colorectal cancer and adenomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494714      PMCID: PMC1968432          DOI: 10.1038/bjc.1993.210

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Optimal dietary conditions for hemoccult testing.

Authors:  F A Macrae; D J St John; P Caligiore; L S Taylor; J W Legge
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

2.  Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects.

Authors:  L Bertario; P Spinelli; L Gennari; P Sala; P Pizzetti; A Severini; G Cozzi; M Bellomi; F Berrino
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

3.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

4.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

5.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

6.  Hemoccult sensitivity estimate in a screening program for colorectal cancer in the Province of Florence.

Authors:  G Castiglione; G Grazzini; A Poli; R Bonardi; S Ciatto
Journal:  Tumori       Date:  1991-06-30
  6 in total
  1 in total

1.  A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Rob Boer; Ann Zauber; J Dik F Habbema
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.